Contravisory Investment Management’s Barclays BCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Sell
396,837
-6,868
-2% -$166K 1.88% 14
2026
Q1
$8.54M Sell
403,705
-23,011
-5% -$561K 1.75% 23
2025
Q4
$10.9M Sell
426,716
-13,124
-3% -$291K 2.15% 10
2025
Q3
$9.09M Sell
439,840
-13,798
-3% -$273K 1.76% 25
2025
Q2
$8.43M Buy
453,638
+438,484
+2,894% +$7.25M 1.66% 27
2025
Q1
$233K Buy
15,154
+529
+4% +$7.92K 0.05% 226
2024
Q4
$194K Buy
+14,625
New +$189K 0.04% 226
2022
Q2
Sell
-10,029
Closed -$79K 331
2022
Q1
$79K Hold
10,029
0.02% 234
2021
Q4
$104K Buy
10,029
+749
+8% +$7.86K 0.03% 213
2021
Q3
$96K Buy
+9,280
New +$92.4K 0.03% 209

Other funds holding BCS

Contravisory Investment Management's BCS Position: Q2 2026 in Review

Contravisory Investment Management reduced its Barclays (BCS) stake by 1.7% in Q2 2026, selling an estimated $166K and leaving 396,837 shares worth $10.7M. The position accounts for 1.88% of the portfolio, ranked #14.

Contravisory Investment Management first reported a position in BCS in Q3 2021 and has held it in 10 quarters since. The position peaked at $10.9M in Q4 2025. 557 funds tracked by Wall St. Rank hold BCS as of Q2 2026.

  • Contravisory Investment Management held 396,837 shares of Barclays worth $10.7M as of Q2 2026.
  • Contravisory Investment Management sold 6,868 Barclays shares in Q2 2026, an estimated $166K.
  • Barclays made up 1.88% of Contravisory Investment Management's portfolio in Q2 2026, its #14 holding.
  • Contravisory Investment Management first reported a position in Barclays in Q3 2021 and has held it in 10 quarters since.
  • Contravisory Investment Management's Barclays position peaked at $10.9M in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Barclays as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.